ENG and cancer: Hong et al. [65] developed novel red fluorescent ZnO nanoparticles and conjugated them with 64Cu (t1/2 = 12.7 h) and TRC105 to construct dual-modality probes targeting CD105, making them a promising candidate for cancer theranostics.